Bruker Launches nVista 2P: A New Generation of Miniature Two-Photon Microscopes Bruker Corporation a global leader in scientific instruments and imaging technologies, has announced the launch of the nVista 2P, a next-generation miniature two-photon (2P) fluorescence microscope that brings deep-tissue,…
Flatiron Health Partners with Veeva to Advance Oncology Research In a significant development for the digital health and clinical research sectors, Flatiron Health—a pioneer in healthtech focused on transforming clinical research—has announced a new strategic partnership with Veeva Systems, a…
PursueCare to Highlight Digital Therapeutics at 2025 Rx Summit in Nashville PursueCare, a leader in virtual addiction treatment and medication-assisted therapy, is pleased to announce its participation in the 2025 Rx and Illicit Drug Summit, taking place April 21–24 in…
Tivic Health Expands Global License for TLR5 Agonist Entolimod to Include Neutropenia Treatment Tivic Health Systems, Inc. , a diversified therapeutics company focused on advancing innovative treatment solutions, has made a significant move in expanding its therapeutic pipeline. On March…
Scipher Medicine and Kythera Labs Join Forces to Advance Autoimmune Disease Treatment In a groundbreaking move aimed at advancing precision medicine in the realm of autoimmune diseases, Scipher Medicine, a leading innovator in precision medicine for autoimmune conditions, has entered…
Nuclera Enhances eProtein Platform to Support Membrane Protein Production Nuclera, a leading biotechnology innovator specializing in rapid protein expression and optimization, today announced a significant enhancement to its flagship benchtop platform, the eProtein Discovery™ system. The company has unveiled a…
ATED Therapeutics Develops Quick and Easy Blood Test for Detecting Parkinson’s Disease In a significant stride toward revolutionizing the diagnosis and monitoring of Parkinson’s disease (PD), UK-based biotech company ATED Therapeutics Ltd. has announced the development of a novel, non-invasive…
IPUMP Enhances Compliance in SLIT Treatment Stallergenes Greer, a global leader in allergy diagnostics and immunotherapy, has announced that it will present compelling findings from its SPEED survey at the upcoming Congrès Francophone d’Allergologie (CFA), the premier French-language congress for…
AdvanCell Announces $18M MRFF Funding for Targeted Prostate Cancer Therapy AdvanCell, a clinical-stage radiopharmaceutical company at the forefront of targeted cancer therapeutics, has received a significant boost from the Australian Federal Government. The company announced today that it has secured…
Vertex’s Paul Negulescu, Ph.D., Wins 2025 Gairdner Award for Cystic Fibrosis Breakthroughs In a landmark moment for both Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and the broader scientific community, Paul Negulescu, Ph.D., Senior Vice President at Vertex, has been named a…
Exicure Announces Plans for New Clinical Trial in Acute Myeloid Leukemia (AML) Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company focused on developing innovative therapeutics targeting diseases with high unmet medical needs, announced significant updates today regarding its lead investigational…
Signios Biosciences Unveils Rebrand and Expands Vision as a Leading Multiomics and AI Bioinformatics Innovator in Precision Medicine In a bold step forward reflecting its evolution and expanded capabilities, Signios Biosciences (formerly the U.S.-based research division of MedGenome Inc.) has…
